摘要
背景:在过去几年中,由于这种系统的明显医疗益处,智能触发的受控药物输送中的释放已经达到了科学界的惊人的兴趣。代表。非全身性给药引起的毒性降低并不是唯一的原因,虽然这是一个主要的原因,通常是在抗癌治疗中,但是。。。另外,一些好的治疗物质由于其高疏水性或由于在所需的输送地点的吸收很差而不能使用。 目的:本综述旨在突出科学界为更有效地触发目的地的药物有效载荷而作出的努力,从而避免系统性的暴露。对药物的毒性作用。 结果:本文对几种触发因素进行了评估,包括pH触发传递、热触发传递、氧化还原改变触发传递以及对tr的修改。依格在特定的位置上基于受体对某种化学成分的亲和力,如叶酸。 结论:通过适当的纳米制剂,系统传递策略所遇到的障碍可以被克服,而疏水药物可以通过一些小的改变通过。对它们的结构进行了微小的修改,同时确保治疗形式被人体自身的内部系统破坏。触发给药的主要优点是:更好的医疗保健策略和局部分娩,在这个案例中获胜的主要人是病人,应该始终是医疗系统的核心。
关键词: 磁性纳米颗粒,药物释放,磁共振成像,触发释放,pH触发传递,热触发传递。
Current Drug Targets
Title:Smart Triggered Release in Controlled Drug Delivery
Volume: 19 Issue: 4
关键词: 磁性纳米颗粒,药物释放,磁共振成像,触发释放,pH触发传递,热触发传递。
摘要: Background: Smart triggered release in controlled drug delivery has met an astonishing interest from the scientific community in the past few years due to the obvious medical benefits this type of systems represents. The reduction in toxicity due to a non-systemic administration is not the only reason for this increase, although it is a major reason for concern typically in anti-cancer therapy, but also the fact that some good therapeutic substances cannot be used either due to their high hydrophobicity or due to a very poor absorption at the required site of delivery.
Objective: This review article aims to highlight the efforts made by the scientific community in order to more efficiently trigger the drug payload at its destination, thus avoiding systemic exposure to the drug's toxic effect.
Results: In this review article several types of triggers have been evaluated, pH triggered delivery, thermally triggered delivery, REDOX change triggered delivery, as well as modifications made to trigger at a specific location based on the affinity of the receptors for a certain chemical moiety, such as folic acid.
Conclusions: Through a proper nano-formulation the obstacles encountered by systemic delivery strategies can be circumvented, and through minor modifications hydrophobic drugs can be delivered through minor modifications to their structure, ensuring in the meantime that the therapeutic form is broken down by the human body’s own internal systems. The main advantages in triggered drug delivery are the better healthcare strategy and the topical delivery, the main person winning in this case being the patient, the one person that should always be at the heart of the medical system.
Export Options
About this article
Cite this article as:
Smart Triggered Release in Controlled Drug Delivery, Current Drug Targets 2018; 19 (4) . https://dx.doi.org/10.2174/1389450117666160401125034
DOI https://dx.doi.org/10.2174/1389450117666160401125034 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanotechnological Strategies for the Treatment of Neglected Diseases
Current Pharmaceutical Design Anti-HER2 Therapy in Elderly Breast Cancer Patients
Reviews on Recent Clinical Trials Targeting Mammalian Target of Rapamycin: Prospects for the Treatment of Inflammatory Bowel Diseases
Current Medicinal Chemistry Lab-on-a-chip Dielectrophoretic Manipulation of Beta-2 Microglobulin for Toxin Removal in An Artificial Kidney
Micro and Nanosystems Nigella sativa and Cancer: A Review Focusing on Breast Cancer, Inhibition of Metastasis and Enhancement of Natural Killer Cell Cytotoxicity
Current Pharmaceutical Biotechnology Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Applied Proteomics in Companion Animal Medicine
Current Proteomics Investigating the Protective Role of Rhodanese Enzyme against Cyanide, the Cytotoxic by-product of Amygdalin, in HDF and L929 Cell Lines
Letters in Drug Design & Discovery Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) Management of Unusual Not Scar Ectopic Pregnancy: A Multicentre Retrospective Case Series
Current Women`s Health Reviews Phytoestrogen Genistein and Its Pharmacological Interactions with Synthetic Endocrine-Active Compounds
Current Pharmaceutical Design MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Current Cancer Drug Targets Influence of Polymer Molecular Weight on in-vitro Characteristics and Cytotoxicity of Fulvestrant Loaded Nanoparticles
Current Drug Therapy The Role of Chinese Herbs and Acupuncture on the Inflammation Reaction After Cerebral Ischemia
Current Pharmaceutical Design Pharmacogenetics of Drug Transporters and Its Impact on the Pharmacotherapy
Current Topics in Medicinal Chemistry New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Editorial
Current Tissue Engineering (Discontinued) Withdrawal Notice: Role, Significance and Association of microRNA-10a/b in Physiology of Cancer
MicroRNA Structural Effects of TiO2 Nanoparticles and Doxorubicin on DNA and their Antiproliferative Roles in T47D and MCF7 Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Recent Patents on Anti-Cancer Drug Discovery